# First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults

> clinical trial · VERIFIED · 2026-06-12

Status: NOT_YET_RECRUITING · Sponsor: GlaxoSmithKline · Condition: Malaria, Falciparum

- Company: GlaxoSmithKline
- Sector: infectious disease
- Primary source: https://clinicaltrials.gov/study/NCT07646353

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.